Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use EMGALITY safely and effectively. See full prescribing information for EMGALITY.EMGALITY (galcanezumab-gnlm) injection, for subcutaneous useInitial U.S. Approval: 2018
Medication labelWhy this: Advisory · dailymed-prescription
EMGALITY is indicated for the preventive treatment of migraine in adults. EMGALITY is indicated for the treatment of episodic cluster headache in adults.
- generic_name
- galcanezumab-gnlm
- product_names
- galcanezumab-gnlm
- ndc
- 0002-1436, 0002-1436-01, 0002-1436-11, 0002-1436-27, 0002-1436-61, 0002-2377, 0002-2377-01, 0002-2377-11, 0002-2377-27, 0002-3115, 0002-3115-01, 0002-3115-09
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en